SCHEMBL5363217

SCHEMBL5363217

Cc1cccc(Oc2ccc(Cl)cc2C(=O)O)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.61
POLB P06746 2/20 0.57
KDM4E B2RXH2 1/20 0.57
MRGPRX4 Q96LA9 2/20 0.55
PTGER4 P35408 2/20 0.52
PTGER2 P43116 1/20 0.48
GFER P55789 2/20 0.48
MAPK1 P28482 1/20 0.48
HTR2C P28335 1/20 0.47
HTR2B P41595 1/20 0.47
GAA P10253 3/20 0.46
TSHR P16473 1/20 0.46
MYC P01106 1/20 0.46
NR4A1 P22736 1/20 0.46
XDH P47989 1/20 0.44
SLC22A12 Q96S37 1/20 0.44
ALDH1A1 P00352 3/20 0.44
CCR2 P41597 1/20 0.44
LMNA P02545 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4445314 0.88 MRGPRX4 (0.60) L3MBTL1POLBKDM4EMRGPRX4PTGER4
SCHEMBL10293213 0.88 POLB (0.63) L3MBTL1POLBKDM4EGFERMAPK1
SCHEMBL30974594 0.88 POLB (0.63) L3MBTL1POLBKDM4EGFERMAPK1
SCHEMBL29250434 0.87 L3MBTL1 (0.63) L3MBTL1KDM4EMRGPRX4PTGER4PTGER2
SCHEMBL30974584 0.87 L3MBTL1 (0.63) L3MBTL1KDM4EMRGPRX4PTGER4PTGER2
SCHEMBL11484213 0.87 MYC (0.49) L3MBTL1POLBKDM4EMRGPRX4PTGER4
SCHEMBL5362837 0.86 L3MBTL1 (0.58) L3MBTL1POLBKDM4EMRGPRX4PTGER4
SCHEMBL30974620 0.86 L3MBTL1 (0.58) L3MBTL1POLBKDM4EMRGPRX4PTGER4
SCHEMBL11485173 0.86 POLB (0.78) L3MBTL1POLBKDM4EMRGPRX4PTGER4
SCHEMBL22891351 0.85 CYP1A2 (0.57) L3MBTL1POLBKDM4EMRGPRX4GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1663979-B1 PHENYL OR PYRIDYL AMIDE COMPOUNDS AS PROSTAGLANDIN E2 ANTAGONISTS RAQUALIA PHARMA INC (JP) 2013-10-09 EP disclosed
CN-1867551-B Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists RAQUALIA PHARMA INC 2013-09-11 CN disclosed
US-7238714-B2 Aryl or heteroaryl amide compounds PFIZER JAPAN, INC. (JP) 2007-07-03 US disclosed
CN-1867551-A Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists PFIZER (US) 2006-11-22 CN disclosed
EP-1663979-A1 PHENYL OR PYRIDYL AMIDE COMPOUNDS AS PROSTAGLANDIN E2 ANTAGONISTS PFIZER INC. (US) 2006-06-07 EP disclosed
US-20050065188-A1 Aryl or heteroaryl amide compounds ASKAT INC. (JP) 2005-03-24 US disclosed
WO-2005021508-A1 PHENYL OR PYRIDYL AMIDE COMPOUNDS AS PROSTAGLANDIN E2 ANTAGONISTS PFIZER INC. (US) 2005-03-10 WO disclosed
US-4242121-A USING A PHENOXYBENZOIC ACID, ITS ESTER OR SALT IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) 1980-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050065188-A1 Aryl or heteroaryl amide compounds HRH2, PTGER1, LTB4R2 L3MBTL1 196/4885POLB 2810/4885KDM4E 875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.